Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children (Q24202700)

5

object named as

Per O Vandvik

0 references

Gordon Guyatt

7

object named as

Gordon H Guyatt

0 references

Bradley C Johnston

8

object named as

Bradley C Johnston

0 references

author name string

Joshua Z Goldenberg

1

0 references

Stephanie SY Ma

2

0 references

Jane D Saxton

3

0 references

Mark R Martzen

Cochrane Database of Systematic Reviews

4

0 references

publication date

31 May 2013

0 references

published in

0 references

cites work

A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotics for the prevention of pediatric antibiotic-associated diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Identification and impact of outcome selection bias in meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Health benefits of probiotics: are mixtures more effective than single strains?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Spontaneously fermented millet product as a natural probiotic treatment for diarrhoea in young children: An intervention study in Northern Ghana

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Impact of mandatory Clostridium difficile surveillance on diagnostic services

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Economic healthcare costs of Clostridium difficile infection: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

The effect of probiotics on Clostridium difficile diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

1 reference

7 January 2021

Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

[Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery - results of a prospective trial].

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotics in human infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Publication bias and dissemination of clinical research.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

The probiotic effect of Saccharomyces boulardii in a pediatric age group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotics for recurrent Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Feasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veterans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Oral supplementation with lactic acid-producing bacteria during intake of clindamycin.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults--a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of a lactobacillus preparation on the absorption of oral ampicillin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Why sources of heterogeneity in meta-analysis should be investigated

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Does taking probiotics routinely with antibiotics prevent antibiotic associated diarrhoea?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A probiotic drink prevented diarrhoea and Clostridium difficile-associated diarrhoea in older patients taking antibiotics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

A multicentre randomised controlled trial evaluating lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea in older people admitted to hospital: the PLACIDE study protocol.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-associated diarrhea treatment: randomized double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Conducting Meta-Analyses in R with the metafor Package

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006095.PUB3

7 January 2021

10.1002/14651858.CD006095.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3074478

3074478

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference